5 Dividend Stocks to Buy in November

These five companies are great stocks for income-hungry dividend investors.

It’s a poorly kept secret that dividends are a large driver of stock market returns. Over the past 25 years, the S&P 500 index has provided investors with a nearly 450% return. However, if investors would have reinvested dividends, their pre-tax return would be approximately 80% higher at 810%. With that in mind, we asked a few Motley Fool contributors their favorite dividend stocks to buy in November.

This dividend is as solid as steel

Neha Chamaria: One dividend stock that’s caught my attention this month is Nucor Corporation (NYSE:NUE). The steelmaker’s recently released third-quarter numbers didn’t go down well with the market, as the company missed analyst estimates, but Nucor delivered a solid quarter in reality, with its net income for the first nine months of the year climbing 30% year over year.

With that kind of growth in profits, shareholders can safely expect Nucor to dole out higher dividends going forward. In fact, Nucor isn’t any other dividend stock. It’s a dividend aristocrat that has increased its dividend for 43 straight years and has paid out a dividend for 174 consecutive quarters now. No other company in its industry boasts such an incredible dividend record. Moreover, Nucor wouldn’t be maintaining such a streak given the cyclicality of steel business if it weren’t financially strong and stable.

In fact, Nucor’s balance sheet is among the strongest in the industry, with limited debt and ample liquid cash. What’s more, the steelmaker generated twice as much free cash flow as net income during the trailing 12 months, which is incredible, as a company pays dividends out of its FCF. So there’s every chance Nucor will be able to maintain its streak of dividend increases in the coming years. With Nucor offering a juicy dividend yield of 3.2%, income investors should consider the stock’s 13% drop in the past three months an opportunity not to be missed.

Microsoft is executing on all levels

Evan Niu, CFA: This might sound a little odd given my obvious bias here, but I’m going to go with Microsoft (NASDAQ:MSFT). The software giant has been firing on all cylinders lately, and much of that is largely thanks to CEO Satya Nadella. For years, investors lacked optimism around the company’s future direction, but Nadella genuinely has them excited again, as he has a much clearer strategic vision than his predecessor, Steve Ballmer. We’re now seeing Microsoft innovate in hardware in a way that we’ve quite literally never seen before. At the same time, the core enterprise business is as strong as ever, with Office continuing to crush iton both the consumer and commercial fronts.



As far as the numbers go, Microsoft’s yield is fairly modest at this point. Shares yield approximately 2.5% at current prices, but this yield is being pushed down, since Microsoft is at all-time highs. Shares are now even higher than they were during the 2000 tech bubble. But the big differencebetween then and now is that the valuation is much more compelling, and cash flow far more sustainable. Sure, there are higher yields out there, even within tech, but I think Microsoft currently presents a compelling combination of reliable income combined with reasonable potential for capital appreciation as long as the company continues to execute under Nadella’s leadership.

Procter & Gamble may be a boring stock, but it has provided investors exciting returns

Jamal Carnette, CFA: The dividend trade has become quite crowded because of historically low interest rates on bonds and other interest-bearing investments. The key is to find a well-run company committed to paying and raising their dividend, and not simply companies that have raised their dividends to take advantage of current investor sentiment. One dividend aristocrat with an amazing dividend history is Procter & Gamble (NYSE:PG).

The consumer-goods company has paid dividends for 126 consecutive years and has increased its dividend for 60 years straight. In the past 30 years, P&G has kicked its rate of dividend increases into high gear by increasing its per-share payout by 9.8% per year through fiscal 2016, a rate much higher than overall inflation during this timeframe. Currently the company trades at a yield of 3.2%, 70 basis points higher than a current 30-year U.S. Treasury bond.

There’s a belief among many investors that a “boring” company like P&G will disappoint as valuations are currently stretched among dividend-paying stocks. Additionally, the company’s core products (Tide, Pampers, and Charmin) are in the uninspiring fast-moving-consumer-goods space.

However, the company has averaged an annual total return of 7.8% over the last 15 years, a full percentage point better than the greater S&P during this period. On a one-year basis, P&G has doubled the index by increasing 12.7%, versus 6%. Still, the company trades at a lower price-to-earnings valuation than the overall S&P index.

Shares recently popped on a positive first-quarter report in which the company beat both EPS and revenue estimates while maintaining full-year sales guidance. Procter & Gamble may be considered boring, but its stable of billion-dollar brands should allow the company to continue to pay and raise dividend payments to investors for years to come.

Things are looking up for this large-cap drugmaker

George Budwell: Merck & Co. (NYSE:MRK) is arguably one of most compelling Big Pharma to stocks to own right now because of Keytruda’s recent approval as a treatment for front-line metastatic non-small-cell lung cancer (NSCLC). The bottom line is that this single indication has the potential to add around $2.5 billion to Keytruda’s annual sales at peak. Moreover, industry experts believe that oncologists will quickly adopt Keytruda as a first-line NSCLC treatment, especially after its main rival, Opdivo, flamed out in late-stage testing for this same indication.



That’s certainly welcome news for shareholders, especially since Merck’s 12-month trailing payout ratio currently stands at a worrisome 100.55%. In other words, Merck’s slightly above-average yield for a major drugmaker of approximately 3% should now be safe. Perhaps most importantly, though, Keytruda’s breakthrough for this high-value indication should act as a magnet for large institutional investors moving forward, helping to drive its share price higher. Wall Street, after all, places a high premium on franchise-level cancer drugs, and Keytruda is undoubtedly on its way toward becoming a top-selling oncology product in the near future.

Growth and yield? Sign me up

Brian Feroldi: It’s rare to find a company that offers up a yield of nearly 4.5% that’s also poised for long-term growth, but that’s exact what Brookfield Infrastructure Partners(NYSE:BIP) offers investors today.

This company is a publicly traded limited partnership that owns and operates infrastructure assets all around the world. Currently, the company owns electrical transmission lines, ports, toll roads, pipelines, rail lines, and more.

What do all of these assets have in common? They are all one of a kind, are irreplaceable, and require huge amounts of capital to build. That means the company doesn’t really have to worry about having a competitor set up shop right next door, which helps make its financial statements highly predictable. In fact, over 90% of its revenue either comes from regulated industries or operates under long-term contracts.

Brookfield’s stability allows its management team to pass along an ever-growing stream of profits back to investors. Since 2009, the company’s distribution has grown by 12% annually, and there are plenty of reasons to expect another payout bump next year.

While there are potential tax ramifications that need to be considered before buying shares, I think this is a great stock for income-focused investors to consider buying today.

6 core dividend stocks for 2016
There’s an important event you’re about to miss. Renowned investors David and Tom Gardner (whose investing newsletter was reported in The Wall Street Journal as one of the best performing in the U.S.*) just released a brand-new report called “6 Core Dividend Stocks for 2016.” You see, copies of this exclusive report are only made available FREE to new members of their service, Motley Fool Stock Advisor. Now, Stock Advisor currently recommends 67 different dividend-paying stocks to members, but after exhaustive research and debate, the team whittled it down to the best 6 dividend stocks to buy today. Act now and also receive a free copy of Stock Advisor‘s 5-point dividend investing playbook, “Your Essential Guide to Dividend Investing.” Click here for details.

*”Look Who’s on Top Now” appeared in The Wall Street Journal in August 2013 which references Hulbert’s rankings of the best performing newsletters over a 5 year period from 2008-2013.

Brian Feroldi has no position in any stocks mentioned. Evan Niu, CFA has no position in any stocks mentioned. George Budwell has no position in any stocks mentioned. Jamal Carnette, CFA has no position in any stocks mentioned. Neha Chamaria has no position in any stocks mentioned. The Motley Fool owns shares of Microsoft. The Motley Fool recommends Brookfield Infrastructure Partners and Nucor. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.



You May Also Like

Pride Week Festival Begins With Tribute to Pulse Nightclub Survivor

Miami Beach Pride’s week-long festivities will commence with a special tribute to the LGBTQ+ community honoring the victims of the tragic shooting at Pulse Nightclub in Orlando. A ceremonial “flip

Surfside luxury condo sees notable sales

Arte at Surfside is making waves. There’s, of course, the news that Ivanka Trump and Jared Kushner are renting at the 16-resident luxury condominium. And there’s the December penthouse sale

Up in the Air: A Discussion

In a dynamic region where residents are typically on the move, everyone is wondering about the health of the airline industry and the safety of airports and airplanes. Everyone is

South Florida Yachting Legend Passes

Robert “Bob” Roscioli, an icon in the South Florida marine industry, has passed away. Many recognize the name Roscioli from the widely-successful and world-renowned Roscioli Yachting Center, a full service

Other Posts

Four key steps

[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column width=”2/3″][vc_column_text] What a crazy time we are all experiencing. Right now, getting back to basics is most important. It is not and

Pandemic adds to worries about hurricane season

An above-normal 2020 Atlantic hurricane season is expected, according to forecasters with NOAA’s Climate Prediction Center, a division of the National Weather Service. The outlook predicts a 60% chance of

The difference between leading and managing

[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column width=”2/3″][vc_column_text] Leadership and management are often misunderstood as one in the same. They are not. Certainly, a good leader should be able

Flattening the housing curve in a pandemic

By Josh Migdal In the classic film Groundhog Day (and yes, it is a classic), Bill Murray’s character wakes up over and over again in Punxsutawney, Pennsylvania, reliving the same

Drew Limsky

Drew Limsky



Drew Limsky joined Lifestyle Media Group in August 2020 as Editor-in-Chief of South Florida Business & Wealth. His first issue of SFBW, October 2020, heralded a reimagined structure, with new content categories and a slew of fresh visual themes. “As sort of a cross between Forbes and Robb Report, with a dash of GQ and Vogue,” Limsky says, “SFBW reflects South Florida’s increasingly sophisticated and dynamic business and cultural landscape.”

Limsky, an avid traveler, swimmer and film buff who holds a law degree and Ph.D. from New York University, likes to say, “I’m a doctor, but I can’t operate—except on your brand.” He wrote his dissertation on the nonfiction work of Joan Didion. Prior to that, Limsky received his B.A. in English, summa cum laude, from Emory University and earned his M.A. in literature at American University in connection with a Masters Scholar Award fellowship.

Limsky came to SFBW at the apex of a storied career in journalism and publishing that includes six previous lead editorial roles, including for some of the world’s best-known brands. He served as global editor-in-chief of Lexus magazine, founding editor-in-chief of custom lifestyle magazines for Cadillac and Holland America Line, and was the founding editor-in-chief of Modern Luxury Interiors South Florida. He also was the executive editor for B2B magazines for Acura and Honda Financial Services, and he served as travel editor for Conde Nast. Magazines under Limsky’s editorship have garnered more than 75 industry awards.

He has also written for many of the country’s top newspapers and magazines, including The New York Times, Washington Post, Los Angeles Times, Miami Herald, Boston Globe, USA Today, Worth, Robb Report, Afar, Time Out New York, National Geographic Traveler, Men’s Journal, Ritz-Carlton, Elite Traveler, Florida Design, Metropolis and Architectural Digest Mexico. His other clients have included Four Seasons, Acqualina Resort & Residences, Yahoo!, American Airlines, Wynn, Douglas Elliman and Corcoran. As an adjunct assistant professor, Limsky has taught journalism, film and creative writing at the City University of New York, Pace University, American University and other colleges.